614 related articles for article (PubMed ID: 23879827)
1. Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011).
Wang A; Smith JR; Creevy KE
J Small Anim Pract; 2013 Aug; 54(8):399-404. PubMed ID: 23879827
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of the combination of glucocorticoids, mycophenolate-mofetil and human immunoglobulin for the therapy of immune mediated haemolytic anaemia in dogs].
Oggier D; Tomsa K; Mevissen M; Glaus T
Schweiz Arch Tierheilkd; 2018 Mar; 160(3):171-178. PubMed ID: 29509140
[TBL] [Abstract][Full Text] [Related]
3. Treatment of presumptive primary immune-mediated thrombocytopenia with mycophenolate mofetil versus cyclosporine in dogs.
Cummings FO; Rizzo SA
J Small Anim Pract; 2017 Feb; 58(2):96-102. PubMed ID: 28160307
[TBL] [Abstract][Full Text] [Related]
4. Use of mycophenolate mofetil to treat immune-mediated skin disease in 14 dogs - a retrospective evaluation.
Ackermann AL; May ER; Frank LA
Vet Dermatol; 2017 Apr; 28(2):195-e44. PubMed ID: 27943548
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Strategies for Treatment of Immune-Mediated Hemolytic Anemia.
Goggs R
Vet Clin North Am Small Anim Pract; 2020 Nov; 50(6):1327-1349. PubMed ID: 32814628
[TBL] [Abstract][Full Text] [Related]
6. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
[TBL] [Abstract][Full Text] [Related]
7. Treatment of idiopathic immune-mediated hemolytic anemia with mycophenolate mofetil in five dogs.
West LD; Hart JR
J Vet Emerg Crit Care (San Antonio); 2014; 24(2):226-31. PubMed ID: 24251650
[TBL] [Abstract][Full Text] [Related]
8. Treatment of five haemodynamically stable dogs with immune-mediated thrombocytopenia using mycophenolate mofetil as single agent.
Yau VK; Bianco D
J Small Anim Pract; 2014 Jun; 55(6):330-3. PubMed ID: 24602067
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial.
Zuckermann A; Reichenspurner H; Birsan T; Treede H; Deviatko E; Reichart B; Klepetko W
J Thorac Cardiovasc Surg; 2003 Apr; 125(4):891-900. PubMed ID: 12698153
[TBL] [Abstract][Full Text] [Related]
10. Sequential therapies for proliferative lupus nephritis.
Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil treatment in dogs with serologically diagnosed acquired myasthenia gravis: 27 cases (1999-2008).
Dewey CW; Cerda-Gonzalez S; Fletcher DJ; Harb-Hauser MF; Levine JM; Badgley BL; Olby NJ; Shelton GD
J Am Vet Med Assoc; 2010 Mar; 236(6):664-8. PubMed ID: 20225980
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002).
Weinkle TK; Center SA; Randolph JF; Warner KL; Barr SC; Erb HN
J Am Vet Med Assoc; 2005 Jun; 226(11):1869-80. PubMed ID: 15934255
[TBL] [Abstract][Full Text] [Related]
13. Influence of drug treatment on survival of dogs with immune-mediated hemolytic anemia: 88 cases (1989-1999).
Grundy SA; Barton C
J Am Vet Med Assoc; 2001 Feb; 218(4):543-6. PubMed ID: 11229506
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil therapy for inflammatory eye disease.
Thorne JE; Jabs DA; Qazi FA; Nguyen QD; Kempen JH; Dunn JP
Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
[TBL] [Abstract][Full Text] [Related]
15. Concurrent immune-mediated haemolytic anaemia and severe thrombocytopenia in 21 dogs.
Goggs R; Boag AK; Chan DL
Vet Rec; 2008 Sep; 163(11):323-7. PubMed ID: 18791206
[TBL] [Abstract][Full Text] [Related]
16. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
Li X; Tian J; Wu J; He Q; Li H; Han F; Li Q; Chen Y; Ni Q; Chen J
Clin Ther; 2009 Apr; 31(4):741-50. PubMed ID: 19446147
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial.
Remuzzi G; Lesti M; Gotti E; Ganeva M; Dimitrov BD; Ene-Iordache B; Gherardi G; Donati D; Salvadori M; Sandrini S; Valente U; Segoloni G; Mourad G; Federico S; Rigotti P; Sparacino V; Bosmans JL; Perico N; Ruggenenti P
Lancet; 2004 Aug 7-13; 364(9433):503-12. PubMed ID: 15302193
[TBL] [Abstract][Full Text] [Related]
18. Treatment of primary immune-mediated hemolytic anemia with mycophenolate mofetil in two cats.
Bacek LM; Macintire DK
J Vet Emerg Crit Care (San Antonio); 2011 Feb; 21(1):45-9. PubMed ID: 21288293
[TBL] [Abstract][Full Text] [Related]
19. Kidney graft outcomes in living-related transplantation have improved with substitution of basiliximab and mycophenolate mofetil for antithymocyte globulin and azathioprine: a single center retrospective cohort study.
Imamović G; Zerem E; Osmanović E
Eur J Intern Med; 2010 Dec; 21(6):524-9. PubMed ID: 21111938
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
Chan TM; Li FK; Tang CS; Wong RW; Fang GX; Ji YL; Lau CS; Wong AK; Tong MK; Chan KW; Lai KN
N Engl J Med; 2000 Oct; 343(16):1156-62. PubMed ID: 11036121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
